Cover Image

Physiologically‐based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate

Abstract This study aimed to determine the effects of pregnancy and ontogeny on risperidone and paliperidone pharmacokinetics by assessing their serum concentrations in two subjects and constructing a customized physiologically‐based pharmacokinetic (PBPK) model. Risperidone and paliperidone serum c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Walaa Y. B. Mahdy (Author), Kazuhiro Yamamoto (Author), Takahiro Ito (Author), Naoko Fujiwara (Author), Kazumichi Fujioka (Author), Tadasu Horai (Author), Ikuo Otsuka (Author), Hitomi Imafuku (Author), Tomohiro Omura (Author), Kazumoto Iijima (Author), Ikuko Yano (Author)
Format:	Book
Published:	Wiley, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
by: Trevor A. Stump, PharmD, BCPP, et al.
Published: (2021)

Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study
by: Takahiro Ito, et al.
Published: (2018)

Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy
by: Kyle Wesselman, PharmD candidate, MA, BS, et al.
Published: (2024)

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
by: Charmi Patel, et al.
Published: (2019)

Incidence of hypospadias in severe small-for-gestational-age infants: A multicenter Asian population study
by: Mariko Ashina, et al.
Published: (2020)

Aggressive posterior retinopathy of prematurity in a preterm infant with congenital hyperinsulinemia without persistent hyperglycemia
by: Mariko Ashina, et al.
Published: (2020)

Three cases of pseudohypoaldosteronism following ileostomy in preterm infants
by: Ruka Nakasone, et al.
Published: (2021)

Head-to-Head Comparison of UHPLC-MS/MS and Alinity C for Plasma Analysis of Risperidone and Paliperidone
by: Francisco José Toja-Camba, et al.
Published: (2024)

Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film
by: Fang Chen, et al.
Published: (2020)

Healthcare Resource Utilization and Costs Among Patients With Schizophrenia Switching From Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis
by: Charmi Patel, MPH, RN, et al.
Published: (2020)

External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data
by: Eleni Karatza, et al.
Published: (2022)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
by: Paula Soria-Chacartegui, et al.
Published: (2021)

Formulation development and pharmacokinetic studies of long acting in situ depot injection of risperidone
by: Vineet Dubey, et al.
Published: (2022)

Successful treatment with olanzapine and aripiprazole of a schizophrenic patient who developed priapism after switching from risperidone to paliperidone
by: Saki Kawahara, et al.
Published: (2024)

Validation of a quick and simple chromatographic method for simultaneous quantification of sertraline, escitalopram, risperidone and paliperidone levels in the human plasma
by: Jeremić Aleksandra, et al.
Published: (2021)

Unraveling enhanced brain delivery of paliperidone-loaded lipid nanoconstructs: pharmacokinetic, behavioral, biochemical, and histological aspects
by: Saleha Rehman, et al.
Published: (2022)

Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse
by: Wonsuk Shin, et al.
Published: (2024)

Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension
by: Ric M Procyshyn, et al.
Published: (2020)

Effect of genetic polymorphisms on the interplay of P-glycoprotein transporter and cytochrome P450 enzymes: Pharmacokinetics of risperidone
by: Yong-Bok Lee
Published: (2016)

Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism
by: Sireen Abdul Rahim Shilbayeh, et al.
Published: (2024)

Feeding interval and use of donor breast milk for very low birthweight infants: A nationwide survey in Japan
by: Mariko Ashina, et al.
Published: (2019)

Pulmonary Hypoplasia Caused by Fetal Ascites in Congenital Cytomegalovirus Infection Despite Fetal Therapy
by: Kazumichi Fujioka, et al.
Published: (2017)

Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human
by: David Bibi, et al.
Published: (2024)

DNA methylation of the Rtl1 promoter in the placentas with fetal growth restriction
by: Kazumichi Fujioka, et al.
Published: (2019)

Effectiveness of pharmacist intervention for deprescribing potentially inappropriate medications: a prospective observational study
by: Takeshi Kimura, et al.
Published: (2022)

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
by: Seyedeh Nesa Rezaeian Shiadeh, et al.
Published: (2023)

Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone
by: Simeon Rüdesheim, et al.
Published: (2022)

Paliperidone to Treat Psychotic Disorders
by: Hormazd D. Minwalla, et al.
Published: (2021)

Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics
by: Kotaro Itohara, et al.
Published: (2022)

Comprehensive analysis including in‐game spending and violent game playing in patients with internet gaming disorder
by: Haruka Minami, et al.
Published: (2024)

Can semipermeable membranes coating materials influence in vivo performance for paliperidone tri-layer ascending release osmotic pump tablet: In vitro evaluation and in vivo pharmacokinetics study
by: Guangjing Li, et al.
Published: (2015)

Prolactin Levels in Schizophrenic Patients Receiving Perospirone in Comparison to Risperidone
by: Takashi Togo, et al.
Published: (2003)

Significance of pharmacist intervention to oral antithrombotic therapy in the pharmaceutical outpatient clinic of cardiovascular internal medicine: a retrospective cohort study
by: Tomoko Kurimura, et al.
Published: (2023)

Population Pharmacokinetics of Dasatinib in Healthy Subjects
by: Walaa B. Hassouneh, et al.
Published: (2024)

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
by: Olivier Corbeil, et al.
Published: (2022)

Risperidone-induced hyperpigmentation
by: Pooja Bains, et al.
Published: (2019)

Risperidone Induced Eruptions
by: Bhatia M . S
Published: (2002)

Risperidone-induced angioedema
by: Caitlin Burton, PharmD, BCPP, et al.
Published: (2024)

Engineering cocrystals of Paliperidone with enhanced solubility and dissolution characteristics
by: Radha-Rani Earle, et al.
Published: (2021)

Association of two variable number of tandem repeats in the monoamine oxidase A gene promoter with suicide completion: The present study and meta‐analysis
by: Masashi Hasegawa, et al.
Published: (2023)